Survival with Cemiplimab in Recurrent Cervical Cancer

Tewari, Krishnansu S ; Monk, Bradley J ; Vergote, Ignace ; Miller, Austin ; de Melo, Andreia C ; Kim, Hee-Seung ; Kim, Yong Man ; Lisyanskaya, Alla ; Samouëlian, Vanessa ; Lorusso, Domenica ; Damian, Fernanda ; Chang, Chih-Long ; Gotovkin, Evgeniy A ; Takahashi, Shunji ; Ramone, Daniella ; Pikiel, Joanna ; Maćkowiak-Matejczyk, Beata ; Guerra Alía, Eva M ; Colombo, Nicoletta ; Makarova, Yulia ; Rischin, Danny ; Lheureux, Stephanie ; Hasegawa, Kosei ; Fujiwara, Keiichi ; Li, Jingjin ; Jamil, Shaheda ; Jankovic, Vladimir ; Chen, Chieh-I ; Seebach, Frank ; Weinreich, David M ; Yancopoulos, George D ; Lowy, Israel ; Mathias, Melissa ; Fury, Matthew G ; Oaknin, Ana

United States: Massachusetts Medical Society

Texto completo disponível

A phase 1/2 study of REGN4336, a PSMAxCD3 bispecific antibody, alone and in combination with cemiplimab in patients with metastatic castration-resistant prostate cancer

Kelly, William Kevin ; Thanigaimani, Pradeep ; Sun, Furong ; Seebach, Frank A. ; Lowy, Israel ; Sandigursky, Sabina ; Miller, Elizabeth

Texto completo disponível

A phase 1/2 study of REGN5093-M114, a METxMET antibody-drug conjugate, in patients with mesenchymal epithelial transition factor (MET)-overexpressing NSCLC

Drilon, Alexander E. ; Awad, Mark M. ; Gadgeel, Shirish M. ; Villaruz, Liza C ; Sabari, Joshua K. ; Perez, Javier ; Daly, Christopher ; Patel, Shraddha ; Li, Siyu ; Seebach, Frank A. ; Lowy, Israel ; Magnan, Heather D. ; Rietschel, Petra

Texto completo disponível

Abstract CT165: Primary analysis of phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma who progressed on or were intolerant to hedgehog inhibitors

Lewis, Karl ; Peris, Ketty ; Sekulic, Aleksander ; Stratigos, Alexander J. ; Dunn, Lara ; Eroglu, Zeynep ; Chang, Anne Lynn S. ; Migden, Michael R. ; Yoo, Suk-Young ; Mohan, Kosalai ; Coates, Ebony ; Okoye, Emmanuel ; Bowler, Timothy ; Baurain, Jean-François ; Bechter, Oliver ; Hauschild, Axel ; Butler, Marcus O. ; Hernandez-Aya, Leonel ; Licitra, Lisa ; Neves, Rogerio I. ; Ruiz, Emily S. ; Seebach, Frank ; Weinreich, David M. ; Yancopoulos, George D. ; Lowy, Israel ; Goncalves, Priscila ; Fury, Matthew G.

Texto completo disponível

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Gross, Neil D. ; Miller, David M. ; Khushalani, Nikhil I. ; Divi, Vasu ; Ruiz, Emily S. ; Lipson, Evan J. ; Meier, Friedegund ; Su, Yungpo B. ; Swiecicki, Paul L. ; Atlas, Jennifer ; Geiger, Jessica L. ; Hauschild, Axel ; Choe, Jennifer H. ; Hughes, Brett G.M. ; Schadendorf, Dirk ; Patel, Vishal A. ; Homsi, Jade ; Taube, Janis M. ; Lim, Annette M. ; Ferrarotto, Renata ; Kaufman, Howard L. ; Seebach, Frank ; Lowy, Israel ; Yoo, Suk-Young ; Mathias, Melissa ; Fenech, Keilah ; Han, Hyunsil ; Fury, Matthew G. ; Rischin, Danny

United States: Massachusetts Medical Society

Texto completo disponível

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial

Gogishvili, Miranda ; Melkadze, Tamar ; Makharadze, Tamta ; Giorgadze, Davit ; Dvorkin, Mikhail ; Penkov, Konstantin ; Laktionov, Konstantin ; Nemsadze, Gia ; Nechaeva, Marina ; Rozhkova, Irina ; Kalinka, Ewa ; Gessner, Christian ; Moreno-Jaime, Brizio ; Passalacqua, Rodolfo ; Li, Siyu ; McGuire, Kristina ; Kaul, Manika ; Paccaly, Anne ; Quek, Ruben G W ; Gao, Bo ; Seebach, Frank ; Weinreich, David M ; Yancopoulos, George D ; Lowy, Israel ; Gullo, Giuseppe ; Rietschel, Petra

United States: Nature Publishing Group

Texto completo disponível

A phase 1/2 study of REGN7075 (EGFRxCD28 costimulatory bispecific antibody) in combination with cemiplimab (anti–PD-1) in patients with advanced solid tumors: Trial-in-progress update

Segal, Neil Howard ; Pelster, Meredith ; Girda, Eugenia ; Fong, Lawrence ; Olszanski, Anthony J. ; Han, Hyunsil ; Casey, Kerry A. ; Li, Siyu ; Welf, Erik ; Chen, Chieh-I ; Skokos, Dimitris ; Seebach, Frank A. ; Lowy, Israel ; Fury, Matthew G. ; Mathias, Melissa Divya ; Lakhani, Nehal J.

Texto completo disponível

Preliminary results from a phase 1/2 study of co-stimulatory bispecific PSMAxCD28 antibody REGN5678 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Stein, Mark N. ; Zhang, Jingsong ; Kelly, William Kevin ; Wise, David R ; Tsao, Kai ; Carneiro, Benedito A. ; Falchook, Gerald Steven ; Sun, Furong ; Govindraj, Shilpa ; Sims, Jennifer S ; Zhu, Min ; Seebach, Frank A. ; Lowy, Israel ; Thanigaimani, Pradeep ; Sandigursky, Sabina ; Miller, Elizabeth

Texto completo disponível

A phase 1/2 study of REGN4336, a PSMAxCD3 bispecific antibody, alone and in combination with cemiplimab in patients with metastatic castration-resistant prostate cancer

Kelly, William Kevin ; Hussain, Arif ; Saraiya, Biren ; Thanigaimani, Pradeep ; Sun, Furong ; Seebach, Frank A. ; Lowy, Israel ; Sandigursky, Sabina ; Miller, Elizabeth

Texto completo disponível

Arabidopsis nicotianamine synthases comprise a common core-NAS domain fused to a variable autoinhibitory C terminus

Seebach, Hiroyuki ; Radow, Gabriel ; Brunek, Michael ; Schulz, Frank ; Piotrowski, Markus ; Krämer, Ute

United States: Elsevier Inc

Texto completo disponível